Data as of Mar 07
| +0.11 / +1.32%|
The 3 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +42.35% increase from the last price of 8.43.
The current consensus among 3 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.